AGENDA
dubai, uae
11 October 2025
07:00 AM - 08:00 AM
REGISTRATION
WORKSHOPS
WORKSHOP-1
08:00 AM - 08:45 AM
RADIOLOGICAL BIOMARKERS IN MS
MODERATOR
DR. MUSTAFA SHAKRA
SPEAKER
DR. MANZOOR AHMED
objectives:
- Identify key MRI features associated with disease activity, progression, & treatment response.
- Interpret radiological findings in the context of current diagnostic criteria, including the 2017 McDonald Criteria.
WORKSHOP-2
08:45 AM - 09:30 AM
Clinical Scale in MS Care
MODERATOR
DR. ALI HASSAN
SPEAKER
DR. REEM ALSUWAIDI
SPEAKER
MRS. GINA LEE
objectives:
- Explore the most commonly used clinical scales in MS, including EDSS, MSFC, and PROMs.
- Develop skills to accurately assess and document neurological disability and functional status.
- Integrate clinical scales into routine MS care to monitor disease progression and evaluate treatment efficacy.
09:30 AM - 09:50 AM
COFFEE BREAK
09:50 AM - 10:00 AM
WELCOME MESSAGE & INTRODUCTION
Dr. MUSTAFA SHAKRA
DR. REEM ALSUWAIDI
EXPANDING HORIZONS IN MS PATHOGENESIS
SESSION 1
moderators
DR. KHALID ALSAFFAR
PROF. JIHAD INSHASI
DR. WAEL EL MASRI
10:00 AM - 10:20 AM
AHSCT in MS: Insights from the UAE Experience
DR. RUQQIA MIR
10:20 AM - 10:40 AM
PIRA and Smoldering MS
Prof. Bassem Yamout
10:40 AM - 11:00 AM
Clinical Approach to Optic Neuritis
DR. MAZEN SABBAH
11:00 AM - 11:20 AM
Clinical Approach to Myelopathy
PROF. MIKLOS SZOLICS
11:20 AM - 11:35 AM
PANEL DISCUSSION
11:35 AM - 11:55 AM
Understanding Tolebrutinib in MS
PROF. JIHAD INSHASI
Prof. Bassem Yamout
11:55 AM - 12:15 PM
The Pillars of Effective MS Management
PROF. JIHAD INSHASI
Dr. reem alsuwaidi
12:15 PM - 12:35 PM
COFFEE BREAK
NEUROFILAMENT IS A RELIABLE GUIDE FOR MS TREATMENT
DEBATE
moderators
Dr. Abubaker Almadani
SPEAKER
tba
SPEAKER
tba
12:35 PM - 12:45 PM
YES
Dr. DEEB KAYED
12:45 PM - 12:55 PM
NO
Dr. MUSTAFA SHAKRA
12:55 PM - 01:00 PM
PANEL DISCUSSION
01:00 PM - 01:20 PM
Long-term outcomes: More than a decade of transformation in MS care
Dr. reem alsuwaidi
DR. POURNAMY SARATHCHANDRAN
01:20 PM - 01:40 PM
Keeping up with the evolution of MS: Are we using anti-CD20s early enough?
Prof. Francesco Saccà
01:40 PM - 02:00 PM
Keeping up with the evolution of MS: Are we using anti-CD20s early enough?
PROF. JIHAD INSHASI
Dr. Ahmed Shatila
02:00 PM - 03:00 PM
LUNCH BREAK
ADVANCES IN MS TREATMENT
SESSION 2
moderators
DR. HALPRASHANTH D.S
DR. MANAL ALFAHHAM
Dr. Ahmed Nizam
03:00 PM - 03:20 PM
EBV and Its Role in MS
DR. VICTORIA MIFSUD
03:20 PM - 03:40 PM
NMOSD and MOGAD
Dr. reem alsuwaidi
03:40 PM - 04:00 PM
NON-MS DEMYLINATING DISEASES IN PEDIATRIC
Dr. Omar Ismayl
04:00 PM - 04:20 PM
Emerging Role of Biomarkers in Demyelinating Diseases
Dr. Hans Frykman
04:20 PM - 04:35 PM
PANEL DISCUSSION
04:35 PM - 04:55 PM
COFFEE BREAK
MS CARE & CLINICAL PRACTICE
SESSION 3
moderators
DR. LAMYA TURKAWI
PROF. MIKLOS SZOLICS
Prof. Suhail Alrukn
04:55 PM - 05:15 PM
BTK Inhibitors in Progressive MS: A New Era
DR. AREEN SAID
05:15 PM - 05:35 PM
Discontinuation of DMT in MS
DR. AHMED SHATILA
05:35 PM - 05:55 PM
Targeted Symptomatic Management in MS
DR. POURNAMY SARATHCHANDRAN
05:55 PM - 06:05 PM
CHALLENGE CASE 1
Dr. Ahmed Hassan
06:05 PM - 06:15 PM
Challenge Case 2
Dr. Maryam Alobeidli
06:15 PM - 06:25 PM
CHALLENGE CASE 3
